Yuji Tajiri
Kurume, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Reduction in extraocular muscle and orbital fat volumes after teprotumumab treatment in Japanese patients with thyroid eye disease: an exploratory magnetic resonance imaging analysis from the OPTIC-J trial.
Journal: Japanese journal of ophthalmology
Published: October 17, 2025
Factors associated with the recurrence of foot ulcers in Japanese patients with diabetes.
Journal: Diabetology international
Published: April 18, 2024
Insulin Resistance Is Better Estimated by Using Fasting Glucose, Lipid Profile, and Body Fat Percent Than by HOMA-IR in Japanese Patients with Type 2 Diabetes and Impaired Glucose Tolerance: An Exploratory Study.
Journal: Metabolic syndrome and related disorders
Published: January 08, 2024
Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in animal model of obese type 2 diabetes.
Journal: Heliyon
Published: April 14, 2022
Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes.
Journal: Diabetology international
Published: October 27, 2020
Distinct Relevance of Nightly Sleep Duration to Metabolic, Anthropometric, and Lifestyle Factors in Patients with Type 2 Diabetes.
Journal: Internal medicine (Tokyo, Japan)
Published: October 22, 2020
Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use.
Journal: Endocrine connections
Published: May 14, 2020
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3.
Journal: The American journal of case reports
Published: November 21, 2019
Pathophysiology of gestational diabetes mellitus in lean Japanese pregnant women in relation to insulin secretion or insulin resistance.
Journal: Diabetology international
Published: November 13, 2019
Voluntary exercise is motivated by ghrelin, possibly related to the central reward circuit.
Journal: The Journal of endocrinology
Published: October 03, 2019
Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report.
Journal: Journal of the Endocrine Society
Published: June 29, 2019
Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.
Journal: Internal medicine (Tokyo, Japan)
Published: June 28, 2019
Last Updated: 09/26/2026